Last updated: October 2026
Yes, most healthy adults can take CBD and ashwagandha together. No harmful interaction between the two has been reported, but no study has tested the combination. Both can cause drowsiness, and both can affect the liver and how some medicines work, so ask a pharmacist first if you take any regular medication.
Avoid ashwagandha, and any product that contains it, if you’re pregnant, breastfeeding, under 18, or have a thyroid, liver or autoimmune condition. Below: how each one works, what the trials actually show, a side-by-side table, how to take them together, who should skip the combination and where both stand in the UK.
Want both in one bottle?
Our Flow CBD Oil combines broad spectrum CBD with ashwagandha and maca in MCT oil, made for your daytime routine, in 500mg or 1000mg. The same cautions apply: avoid it if you are pregnant, breastfeeding, under 18, or have a thyroid, liver or autoimmune condition. Prefer CBD without ashwagandha? Our Broad Spectrum CBD Oil is just CBD and MCT oil.
Add Flow CBD Oil 500mg to bag or choose another strength
Broad spectrum with 0% THC, every batch third-party lab tested, made in the UK. Free UK delivery over £45, 14-day returns on unopened items.
Can you take CBD and ashwagandha together?
For most healthy adults, yes. They are very different substances: CBD is a non-intoxicating compound from hemp that acts on the body’s endocannabinoid system, while ashwagandha is the root of Withania somnifera, an Ayurvedic herb studied mainly for stress, cortisol and sleep. No harmful interaction between the two has been reported, and you can take them at the same time of day.
Researching CBD and pain? Our best CBD oil for pain UK guide covers strengths, spectrum and lab reports, and what the research does and does not show.
“No reported interaction” isn’t the same as “tested and proven safe”, though. Nobody has run a trial of the two together, so the sensible approach is to look at where their known effects overlap. There are three places:
- Drowsiness. Both can make some people sleepy. Taken together, or alongside other sedating supplements, the effect may add up.
- The liver. CBD at high doses can raise liver enzymes, and ashwagandha has been linked to rare cases of liver injury. Neither is common at supplement doses, but together they are a reason to avoid the combination if you have liver disease.
- Medicines. CBD is broken down by liver enzymes (mainly CYP2C19 and CYP3A4) and can change levels of some prescription medicines. Ashwagandha may add to the effect of sedatives and can affect thyroid hormone levels. If you take any regular medication, check with your GP or pharmacist first.
For the full list of medicines to ask about, see can CBD interact with medication? and the interactions section of our ashwagandha side effects guide.
CBD vs ashwagandha vs taking both
| CBD | Ashwagandha | Taking both | |
|---|---|---|---|
| What it is | A non-intoxicating compound from hemp | The root (sometimes leaf) of Withania somnifera | Two products, or one combined oil |
| Main research areas | Anxiety in short-term lab tests; sleep (early research) | Stress, cortisol, sleep and anxiety scores | Not studied |
| Strength of human evidence | Small trials, mostly single doses of 300 to 600mg | Several small trials and meta-analyses, rated low certainty | None |
| Amounts | FSA advice: no more than 10mg a day for healthy adults | Trials used 240 to 600mg of root extract a day | Follow each label; don’t stack extra ashwagandha products |
| Trial timescales | Single doses, measured within hours | 8 to 10 weeks of daily use | Not known |
| Drowsiness | Possible | Possible | May add up |
| Liver | Enzyme rises at high doses | Rare case reports of liver injury | Avoid if you have liver disease |
| Avoid if | Pregnant, breastfeeding, under 18; check medicines | Pregnant, breastfeeding, under 18; thyroid, liver or autoimmune conditions; check medicines | Any of these |
What the research says about ashwagandha
Ashwagandha has more human trials than most herbs, mostly in adults who described themselves as stressed. Here are the main ones:
| Study | What it found |
|---|---|
| Chandrasekhar, 2012 (64 stressed adults, 60 days, 300mg twice a day) | Lower scores on stress questionnaires and lower cortisol than placebo |
| Salve, 2019 (60 stressed adults, 8 weeks, 250mg or 600mg a day) | Lower perceived stress scores and lower cortisol than placebo at both doses |
| Lopresti, 2019 (60 stressed adults, 60 days, 240mg a day) | A small but significant drop in anxiety ratings and lower morning cortisol than placebo; the stress questionnaire change was not significant |
| Langade, 2019 (60 adults with insomnia, 10 weeks, 300mg twice a day) | Fell asleep a little faster and had better sleep efficiency on a wrist monitor than placebo |
| Cheah, 2021 (review of 5 trials, 400 people) | A small but significant effect on overall sleep, stronger at 600mg a day or more and over 8 weeks or longer |
| Akhgarjand, 2022 (review of 12 trials, about 1,000 people) | Lower anxiety and stress scores than placebo, but the authors rated the certainty of the evidence as low |
Keep the caveats in mind. Most trials are small, last 8 to 10 weeks and were run in India using specific branded root extracts, so the results may not apply to every product. Ashwagandha also has no authorised health claims in Great Britain: it isn’t on the GB nutrition and health claims register, so no brand can legally say it reduces stress or improves sleep.
On safety, a 2026 review of 23 trials in 2,317 healthy adults found liver, kidney, blood and hormone markers stayed within normal ranges at 125 to 600mg a day of standardised root extract, for up to six months. Trials are too small to pick up rare reactions, though, and there is very little data beyond six months. More detail: ashwagandha and anxiety studies, ashwagandha and sleep and is ashwagandha safe?
What the research says about CBD
CBD’s best-known results come from short-term controlled studies. In one, 24 people with social anxiety disorder took a single 600mg dose of CBD or a placebo before a simulated public speaking test, and the CBD group reported less anxiety and discomfort. That is around 60 times the FSA’s 10mg a day advice, so it tells us little about everyday supplement amounts.
If you’re weighing up CBD for everyday calm, our best CBD oil for anxiety UK guide explains what to check and what the research does and doesn’t show.
At lower amounts, the evidence is weaker. In a 2019 US case series, 72 adults at a psychiatric clinic took mostly 25mg a day alongside their usual treatment. Anxiety scores fell in about four in five people in the first month, and sleep scores improved in about two in three but went up and down over time. There was no placebo group, so we can’t tell how much was down to CBD.
The honest summary: CBD isn’t a treatment for anxiety, sleep problems or any other condition, and the research on everyday doses is still early. Read the full picture in CBD and anxiety: what the research shows, CBD for sleep and CBD side effects.
CBD or ashwagandha: which should you choose?
There is no head-to-head trial, so nobody can tell you one is better. What we can compare is the evidence and the safety profile:
- On research volume, ashwagandha has more controlled trials in stressed adults, measured over weeks. CBD’s research is mostly single high doses in lab settings.
- On who can take it, CBD has fewer exclusions. Ashwagandha is off the table if you’re pregnant or have a thyroid, liver or autoimmune condition, and it is under safety review in the UK.
- On medicines, both need a check, but for different reasons: CBD for how medicines are broken down, ashwagandha for sedatives, thyroid and immune medicines.
- On routine, ashwagandha trials used daily doses for 8 weeks or more. CBD can be taken daily or only on some days.
iIf stress, low mood or poor sleep is affecting your daily life, see your GP first: neither CBD nor ashwagandha is a substitute for proper help. If you’re comparing herbs, see reishi vs ashwagandha and ashwagandha vs magnesium.
Why people combine them
The idea is that they cover different bases. Ashwagandha has been studied as a daily, weeks-long habit, while CBD is something many people take as part of a daily routine at a time that suits them. Plenty of people simply prefer one bottle to two.
That’s the theory. No study has yet tested CBD and ashwagandha together, so any extra benefit from combining them is unproven. If you try both, do it carefully, and stop if you notice anything you don’t like.
How to take CBD and ashwagandha together
- Start one at a time if you’re new to both, so you know how each affects you. Or start with a combined oil at the lowest amount.
- Pick your time of day. Most people take them in the morning or at lunch. If either makes you drowsy, switch to the evening, and don’t drive until you know how they affect you.
- Take them with food or water, at the same time each day. In the trials, ashwagandha was taken once or twice a day, with milk or water in one insomnia study. See when to take ashwagandha.
- Start low with CBD, around 10mg a day, and increase slowly if needed. See CBD dosage and when to take CBD oil.
- Don’t double up on ashwagandha. If your CBD oil already contains it, don’t add a separate ashwagandha capsule on top.
- Take breaks from ashwagandha. Most trials lasted 8 to 12 weeks, and there’s little data on longer use, so many people take a few weeks off after that.
The FSA’s 10mg a day figure is precautionary advice rather than a legal limit, set while longer-term safety research continues. At Evopure we think it is a very cautious figure, and many adults use more. If you go above it, increase slowly, and check with your GP or pharmacist first if you take any medication.
Many people use Flow by day and our Sleep CBD Oil or Magnesium Sleep Complex in the evening. If you combine several products, add up the CBD from each.
Side effects and who should avoid them
Possible side effects of either include drowsiness, an upset stomach, diarrhoea and changes in appetite. In an FDA trial, 5.6% of healthy adults taking about 5mg of CBD per kg of body weight a day (around 350mg for a 70kg adult) had raised liver enzymes, which is far more than a typical supplement. Rarely, ashwagandha has been linked to liver injury and thyroid changes: in one case series it appeared after 2 to 12 weeks of use and cleared after stopping, but in another, people with existing liver disease had serious outcomes.
iAvoid the combination, or speak to your GP first, if you:
- are pregnant, trying to conceive or breastfeeding (see ashwagandha and breastfeeding and CBD in pregnancy)
- are under 18
- have a thyroid condition or take thyroid medication
- have liver disease, or an autoimmune condition such as rheumatoid arthritis, lupus or MS
- have hormone-sensitive prostate cancer
- take sedatives, sleeping tablets, anti-seizure medicines, antidepressants or anti-anxiety medicines
- take blood thinners, immunosuppressants, or medicines for diabetes or blood pressure
- take any medicine with a grapefruit warning
- have surgery planned within two weeks
We don’t recommend our products during pregnancy or breastfeeding, and all our products are for adults (18+) only.
Warning signs: stop taking ashwagandha and CBD and see your GP if you notice yellow skin or eyes, dark urine, pale stools, persistent itching or unusual tiredness. Tell them which supplements you’ve been taking. More on this in is CBD bad for your liver?
CBD and ashwagandha rules in the UK
| CBD | Ashwagandha | |
|---|---|---|
| Legal to sell? | Yes, as a novel food. Products must be linked to an application on the FSA’s public list | Yes, as a food supplement |
| Official intake advice | FSA: no more than 10mg a day for healthy adults (precautionary) | No safe level set and no formal FSA advice yet; while the review continues, the FSA told Which? (June 2026) it would advise pregnant women and people with liver conditions to avoid it |
| Authorised health claims | None | None |
| Under review? | First novel food authorisations recommended in 2026 | Yes: the Committee on Toxicity discussed a third draft statement in September 2026 |
Ashwagandha is legal to sell as a food supplement in the UK. The FSA asked its Committee on Toxicity (COT) to review its safety, including effects on thyroid hormones, blood sugar and the liver. The COT discussed a third draft statement in private in September 2026, and nothing has been published yet. Denmark banned ashwagandha in food supplements in 2023, and the Netherlands has advised consumers against using it. For the full timeline, see where the UK ashwagandha safety review stands.
For CBD, see the FSA’s first CBD approvals explained and what the FSA’s 10mg advice really means. All Evopure CBD products are broad spectrum with 0% THC and are on the FSA public list, linked to validated applications.
Related guides
- What does ashwagandha do?
- Full spectrum vs broad spectrum vs isolate CBD
- Taking CBD with other supplements? See CBD and turmeric: safety and medicines to check.
- Curious about the research in men specifically? Read ashwagandha for men.
- On its own, ashwagandha trials used set amounts: see how much ashwagandha per day.
- Buying on the high street? See Holland and Barrett ashwagandha: KSM-66, strengths and UK safety.
- Grass and Co CALM, a CBD oil made with ashwagandha, chamomile and mint.
- If you’re comparing ashwagandha products, see Wild Nutrition ashwagandha too.
- If you’re comparing ashwagandha extracts, our KSM-66 ashwagandha guide covers root-only extracts, trial doses and UK safety.
- Comparing an oil with gummies or capsules? See liquid ashwagandha vs gummies, capsules and powder.
- Ashwagandha trials measured changes over weeks, not hours: see how long ashwagandha takes to work.
- Taking Flow with your first coffee? See CBD coffee for what the evidence says on CBD and caffeine.
- Buying ashwagandha on the high street? See what Boots, Superdrug, Tesco and Asda sell.
- Planning ahead? Our Black Friday CBD oil deals run from 27 to 30 November 2026, with up to 40% off.
What’s in Flow CBD Oil
Our Flow CBD Oil is a daytime CBD oil that puts both in one bottle. It contains:
- Broad spectrum CBD from hemp, with 0% THC
- Ashwagandha root extract
- Maca root extract (read about maca root)
- Coconut MCT oil as the carrier
- Our Energise terpene blend of citral, phellandrene, terpineol and beta ocimene, which gives it a citrus taste (see what are terpenes?)
It comes in 10ml bottles of 500mg (5%) or 1000mg (10%) CBD, which works out at about 2.5mg or 5mg of CBD per drop. It is vegan, UK-made and third-party lab tested, with reports on our lab testing page. Because it contains ashwagandha, everything in the safety section above applies to it, and we make no health claims for it.
Sources 21
- Chandrasekhar K et al (2012). A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian Journal of Psychological Medicine. PMID 23439798.
- Salve J et al (2019). Adaptogenic and anxiolytic effects of ashwagandha root extract in healthy adults: a double-blind, randomized, placebo-controlled clinical study. Cureus. PMID 32021735.
- Lopresti AL et al (2019). An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract. Medicine (Baltimore). PMID 31517876.
- Langade D et al (2019). Efficacy and safety of ashwagandha root extract in insomnia and anxiety. Cureus. PMID 31728244.
- Cheah KL et al (2021). Effect of ashwagandha extract on sleep: a systematic review and meta-analysis. PLoS One. PMID 34559859.
- Akhgarjand C et al (2022). Does ashwagandha supplementation have a beneficial effect on the management of anxiety and stress? Phytotherapy Research. PMID 36017529.
- Coope OC et al (2026). Safety and tolerability of standardised ashwagandha root extract in healthy adults: a systematic review of biomarkers and adverse events. Pharmaceuticals. PMID 42198398.
- Björnsson HK et al (2020). Ashwagandha-induced liver injury: a case series from Iceland and the US Drug-Induced Liver Injury Network. Liver International. PMID 31991029.
- Philips CA et al (2023). Ashwagandha-induced liver injury: a case series from India and literature review. Hepatology Communications. PMID 37756041.
- Bergamaschi MM et al (2011). Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients. Neuropsychopharmacology. PMID 21307846.
- Shannon S et al (2019). Cannabidiol in anxiety and sleep: a large case series. The Permanente Journal. PMID 30624194.
- Brown JD, Winterstein AG (2019). Potential adverse drug events and drug-drug interactions with medical and consumer cannabidiol (CBD) use. Journal of Clinical Medicine. PMID 31288397.
- Florian J et al (2025). Cannabidiol and liver enzyme level elevations in healthy adults: a randomized clinical trial. JAMA Internal Medicine. PMID 40622698.
- Memorial Sloan Kettering Cancer Center. Ashwagandha: herb-drug interactions and warnings, updated July 2026.
- Which?. Ashwagandha: stress buster or health risk? (includes the FSA’s interim comment), June 2026.
- FSA. Summary of responses to call for evidence on ashwagandha, 25 June 2026.
- COT. Draft minutes of the 8 September 2026 COT meeting (item 5: third draft statement on ashwagandha).
- NutraIngredients. Timeline: will authorities de-throne the King of Herbs?, July 2026.
- Food Standards Agency. Cannabidiol (CBD) guidance.
- Food Standards Agency. Provisional cannabidiol (CBD) acceptable daily intake (ADI), October 2023.
- DHSC. Great Britain nutrition and health claims (NHC) register, May 2026.
This guide is general information, not medical advice. Evopure makes Flow CBD Oil.

































